1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Smart Insulin or Glucose Responsive Insulin Market by Delivery Devices, Disease, and Type : Global Opportunity Analysis and Industry Forecast, 2019–2027

Smart Insulin or Glucose Responsive Insulin Market by Delivery Devices, Disease, and Type : Global Opportunity Analysis and Industry Forecast, 2019–2027

  • August 2020
  • 231 pages
  • ID: 5976896
  • Format: PDF
  • Allied Market Research

Summary

Table of Contents

Smart Insulin or Glucose Responsive Insulin Market by Delivery Devices (Smart Insulin Pen and Smart Insulin Pump), Disease, (Type 1 Diabetes and Type 2 Diabetes), and Type (Rapid Acting, Intermediate Acting, Long Acting, Short Acting, and Premixed Type): Global Opportunity Analysis and Industry Forecast, 2019–2027

The global smart insulin or glucose responsive insulin market was valued at $2,773.73 million in 2019 and is expected to reach $6,174.30 million by 2027, registering a CAGR of 10.5 % from 2020 to 2027. Smart insulin or glucose-responsive insulin is a next generation insulin that automatically responds to changing blood glucose levels. It helps in management of blood glucose level of diabetic patients in minimally invasive manner. It is a painless mode of introducing insulin compared to injectable insulin, reducing the risk of skin irritation caused due to needles. Advanced diabetic therapy in the form of insulin patches, insulin pens, continuous glucose monitoring systems (CGMS), and artificial pancreas help to improve management of blood sugar level and decrease the possibility of any diabetic-related difficulty.
Smart insulin is used to deliver insulin into diabetic patients. Increase in demand for self-injection devices, rise in prevalence of diabetes, and accuracy in dosage delivery of insulin are expected to drive the market growth. The market is expected to witness an exponential growth during the forecast period, owing to benefits of using these advanced devices over conventional products and increase in healthcare expenses. Moreover, rise in the incidences of diabetes globally and increase in diabetic patients are expected to boost the market growth. As per data published by the NCBI (National Center for Biotechnology Information) in 2016, six million people with diabetes used insulin either alone or in combination with an oral medication. However, lack of awareness, cost restrains in developing regions, and less variability in products are expected to hinder the market growth. Development of affordable products with fewer side effects and presence of undiagnosed diabetic patients globally are expected to provide opportunities for the market growth.
The smart insulin or glucose responsive insulin market is segmented on the basis of type, disease, delivery devices, and region. By type, it is divided into rapid-acting, intermediate-acting, long-acting, short-acting and pre-mixed type. On the basis of disease, it is bifurcated into Type 1 and Type 2 diabetes. On the basis of delivery devices, it is classified into smart insulin pen and smart insulin pump.
Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the majority of the market share in 2019, and is anticipated to continue this trend during the forecast period. North America holds a dominant share in the global Smart Insulin or Glucose Responsive Insulin market, because well-developed supply-side infrastructure, rapid acceptance of innovative technologies, and adequate reimbursements have fuelled the growth of the North American smart insulin or glucose responsive insulin market. Asia Pacific is expected to continue the trend throughout the forecast period, because growth is increase in diabetic population across the region.

KEY MARKET SEGMENTS

By Delivery Devices
• Smart Insulin Pen
• Smart Insulin Pump
o Tethered Insulin Pumps
o Insulin Patch Pumps

By Disease
• Type 1 Diabetes
• Type 2 Diabetes

By Type
• Rapid Acting
• Intermediate Acting
• Long Acting
• Short Acting
• Premixed Type

By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
• CeQur
• Diamesco Co
• Eli lily and Company
• F. Hoffmann-La Roche AG
• Insulet Corporation
• Medtronic Plc
• Novo Nordisk A/S.
• Sanofi
• Zealand Pharma

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Smart Insulin Pens Global Market Report 2021: COVID-19 Growth And Change To 2030

  • $ 4000
  • April 2021
  • 175 pages

Major players in the smart insulin pens market are Companion Medical, Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co. Ltd., Emperra GmbH E-Health Technologies, Digital Medics Pvt Ltd., F. Hoffmann-La ...

  • United States
  • APAC
  • Insulin Delivery
  • Insulin
  • Industry analysis
  • Medical Technology Density

ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on